India Rejects Pharma Industry Offer To Avoid Expanded Price Controls
This article was originally published in PharmAsia News
India's government rejected an offer by the nation's drug makers to lower prices on essential drugs. The Indian Pharmaceutical Alliance had offered to sell some of its members' most popular drugs to the government at half price if it would drop a proposal to expand drug price controls. The government rejected the proposal and continued with plans to complete a new pricing policy by the end of April. A source said the government negotiated with drug makers to lower the prices to the public and not just to the government. (Click here for more
You may also be interested in...
Coverage Decisions For AlloMap Molecular Testing To Detect Cardiac Allograft Rejections Left Up To MACs
The US CMS has proposed that due to low Medicare use, it will not nationally cover AlloMap molecular tests to detect cardiac allograft rejections.
Manufacturers considering use of the popular 99.99% germ-kill claim on hand sanitizer products should consult the Office of Compliance, said Division of Nonprescription Drug Products director Theresa Michele during a recent industry workshop. “Be very, very cautious about the claims you are making,” she said.
Change in leadership at the European Medicines Agency comes at a critical time.